| Pharmaceutical Information |
| Drug Name |
Monobenzone |
| Drug ID |
BADD_D01493 |
| Description |
Monobenzone is the monobenzyl ether of hydroquinone used medically for depigmentation. Monobenzone occurs as a white, almost tasteless crystalline powder, soluble in alcohol and practically insoluble in water. It exerts a depigmenting effect on skin of mammals by increasing the excretion of melanin from the melanocytes. It may also cause destruction of melanocytes and permanent depigmentation. |
| Indications and Usage |
Used topically to treat the loss of skin color (vitiligo). |
| Marketing Status |
approved |
| ATC Code |
D11AX13 |
| DrugBank ID |
DB00600
|
| KEGG ID |
D05072
|
| MeSH ID |
C006429
|
| PubChem ID |
7638
|
| TTD Drug ID |
D0H6TP
|
| NDC Product Code |
71052-111; 73309-070 |
| UNII |
9L2KA76MG5
|
| Synonyms |
monobenzone | hydroquinone monobenzyl ether | agerite alba | monobenzyl ether hydroquinone | p-(benzyloxy)phenol | Benoquin | Novo-depigman |
|
| Chemical Information |
| Molecular Formula |
C13H12O2 |
| CAS Registry Number |
103-16-2 |
| SMILES |
C1=CC=C(C=C1)COC2=CC=C(C=C2)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
